List of Tables
Table 1. Novel Drug Delivery Systems Market Trends
Table 2. Novel Drug Delivery Systems Market Drivers & Opportunity
Table 3. Novel Drug Delivery Systems Market Challenges
Table 4. Novel Drug Delivery Systems Market Restraints
Table 5. Global Novel Drug Delivery Systems Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Novel Drug Delivery Systems Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Novel Drug Delivery Systems Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Novel Drug Delivery Systems Product Type
Table 9. Key Companies Time to Begin Mass Production of Novel Drug Delivery Systems
Table 10. Global Novel Drug Delivery Systems Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Drug Delivery Systems as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Novel Drug Delivery Systems Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Novel Drug Delivery Systems Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Novel Drug Delivery Systems Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Novel Drug Delivery Systems Sales Market Share in Value by Type (2020-2025)
Table 17. Global Novel Drug Delivery Systems Sales Market Share in Value by Type (2026-2031)
Table 18. Global Novel Drug Delivery Systems Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Novel Drug Delivery Systems Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Novel Drug Delivery Systems Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Novel Drug Delivery Systems Sales Market Share in Value by Application (2020-2025)
Table 22. Global Novel Drug Delivery Systems Sales Market Share in Value by Application (2026-2031)
Table 23. Global Novel Drug Delivery Systems Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Novel Drug Delivery Systems Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Novel Drug Delivery Systems Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Novel Drug Delivery Systems Sales Value by Region (2020-2025) & (%)
Table 27. Global Novel Drug Delivery Systems Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Novel Drug Delivery Systems Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Novel Drug Delivery Systems Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Novel Drug Delivery Systems Sales Value, (2026-2031) & (US$ Million)
Table 31. Amgen Basic Information List
Table 32. Amgen Description and Business Overview
Table 33. Amgen Novel Drug Delivery Systems Products, Services and Solutions
Table 34. Revenue (US$ Million) in Novel Drug Delivery Systems Business of Amgen (2020-2025)
Table 35. Amgen Recent Developments
Table 36. Teva Basic Information List
Table 37. Teva Description and Business Overview
Table 38. Teva Novel Drug Delivery Systems Products, Services and Solutions
Table 39. Revenue (US$ Million) in Novel Drug Delivery Systems Business of Teva (2020-2025)
Table 40. Teva Recent Developments
Table 41. Roche Basic Information List
Table 42. Roche Description and Business Overview
Table 43. Roche Novel Drug Delivery Systems Products, Services and Solutions
Table 44. Revenue (US$ Million) in Novel Drug Delivery Systems Business of Roche (2020-2025)
Table 45. Roche Recent Developments
Table 46. UCB (Union Chimique Belge) Basic Information List
Table 47. UCB (Union Chimique Belge) Description and Business Overview
Table 48. UCB (Union Chimique Belge) Novel Drug Delivery Systems Products, Services and Solutions
Table 49. Revenue (US$ Million) in Novel Drug Delivery Systems Business of UCB (Union Chimique Belge) (2020-2025)
Table 50. UCB (Union Chimique Belge) Recent Developments
Table 51. Celgene Basic Information List
Table 52. Celgene Description and Business Overview
Table 53. Celgene Novel Drug Delivery Systems Products, Services and Solutions
Table 54. Revenue (US$ Million) in Novel Drug Delivery Systems Business of Celgene (2020-2025)
Table 55. Celgene Recent Developments
Table 56. Merck Basic Information List
Table 57. Merck Description and Business Overview
Table 58. Merck Novel Drug Delivery Systems Products, Services and Solutions
Table 59. Revenue (US$ Million) in Novel Drug Delivery Systems Business of Merck (2020-2025)
Table 60. Merck Recent Developments
Table 61. Gilead Sciences Basic Information List
Table 62. Gilead Sciences Description and Business Overview
Table 63. Gilead Sciences Novel Drug Delivery Systems Products, Services and Solutions
Table 64. Revenue (US$ Million) in Novel Drug Delivery Systems Business of Gilead Sciences (2020-2025)
Table 65. Gilead Sciences Recent Developments
Table 66. Sanofi Basic Information List
Table 67. Sanofi Description and Business Overview
Table 68. Sanofi Novel Drug Delivery Systems Products, Services and Solutions
Table 69. Revenue (US$ Million) in Novel Drug Delivery Systems Business of Sanofi (2020-2025)
Table 70. Sanofi Recent Developments
Table 71. Pfizer Basic Information List
Table 72. Pfizer Description and Business Overview
Table 73. Pfizer Novel Drug Delivery Systems Products, Services and Solutions
Table 74. Revenue (US$ Million) in Novel Drug Delivery Systems Business of Pfizer (2020-2025)
Table 75. Pfizer Recent Developments
Table 76. Takeda Basic Information List
Table 77. Takeda Description and Business Overview
Table 78. Takeda Novel Drug Delivery Systems Products, Services and Solutions
Table 79. Revenue (US$ Million) in Novel Drug Delivery Systems Business of Takeda (2020-2025)
Table 80. Takeda Recent Developments
Table 81. Bausch&Lomb Basic Information List
Table 82. Bausch&Lomb Description and Business Overview
Table 83. Bausch&Lomb Novel Drug Delivery Systems Products, Services and Solutions
Table 84. Revenue (US$ Million) in Novel Drug Delivery Systems Business of Bausch&Lomb (2020-2025)
Table 85. Bausch&Lomb Recent Developments
Table 86. Samyang Biopharmaceuticals Basic Information List
Table 87. Samyang Biopharmaceuticals Description and Business Overview
Table 88. Samyang Biopharmaceuticals Novel Drug Delivery Systems Products, Services and Solutions
Table 89. Revenue (US$ Million) in Novel Drug Delivery Systems Business of Samyang Biopharmaceuticals (2020-2025)
Table 90. Samyang Biopharmaceuticals Recent Developments
Table 91. Johnson & Johnson Basic Information List
Table 92. Johnson & Johnson Description and Business Overview
Table 93. Johnson & Johnson Novel Drug Delivery Systems Products, Services and Solutions
Table 94. Revenue (US$ Million) in Novel Drug Delivery Systems Business of Johnson & Johnson (2020-2025)
Table 95. Johnson & Johnson Recent Developments
Table 96. TOLMAR Basic Information List
Table 97. TOLMAR Description and Business Overview
Table 98. TOLMAR Novel Drug Delivery Systems Products, Services and Solutions
Table 99. Revenue (US$ Million) in Novel Drug Delivery Systems Business of TOLMAR (2020-2025)
Table 100. TOLMAR Recent Developments
Table 101. Astellas Basic Information List
Table 102. Astellas Description and Business Overview
Table 103. Astellas Novel Drug Delivery Systems Products, Services and Solutions
Table 104. Revenue (US$ Million) in Novel Drug Delivery Systems Business of Astellas (2020-2025)
Table 105. Astellas Recent Developments
Table 106. AMAG Pharmaceuticals Basic Information List
Table 107. AMAG Pharmaceuticals Description and Business Overview
Table 108. AMAG Pharmaceuticals Novel Drug Delivery Systems Products, Services and Solutions
Table 109. Revenue (US$ Million) in Novel Drug Delivery Systems Business of AMAG Pharmaceuticals (2020-2025)
Table 110. AMAG Pharmaceuticals Recent Developments
Table 111. AbbVie Basic Information List
Table 112. AbbVie Description and Business Overview
Table 113. AbbVie Novel Drug Delivery Systems Products, Services and Solutions
Table 114. Revenue (US$ Million) in Novel Drug Delivery Systems Business of AbbVie (2020-2025)
Table 115. AbbVie Recent Developments
Table 116. Dr Reddy Basic Information List
Table 117. Dr Reddy Description and Business Overview
Table 118. Dr Reddy Novel Drug Delivery Systems Products, Services and Solutions
Table 119. Revenue (US$ Million) in Novel Drug Delivery Systems Business of Dr Reddy (2020-2025)
Table 120. Dr Reddy Recent Developments
Table 121. AstraZeneca Basic Information List
Table 122. AstraZeneca Description and Business Overview
Table 123. AstraZeneca Novel Drug Delivery Systems Products, Services and Solutions
Table 124. Revenue (US$ Million) in Novel Drug Delivery Systems Business of AstraZeneca (2020-2025)
Table 125. AstraZeneca Recent Developments
Table 126. Aspen Basic Information List
Table 127. Aspen Description and Business Overview
Table 128. Aspen Novel Drug Delivery Systems Products, Services and Solutions
Table 129. Revenue (US$ Million) in Novel Drug Delivery Systems Business of Aspen (2020-2025)
Table 130. Aspen Recent Developments
Table 131. Acrotech Biopharma Basic Information List
Table 132. Acrotech Biopharma Description and Business Overview
Table 133. Acrotech Biopharma Novel Drug Delivery Systems Products, Services and Solutions
Table 134. Revenue (US$ Million) in Novel Drug Delivery Systems Business of Acrotech Biopharma (2020-2025)
Table 135. Acrotech Biopharma Recent Developments
Table 136. TWi Pharmaceuticals Basic Information List
Table 137. TWi Pharmaceuticals Description and Business Overview
Table 138. TWi Pharmaceuticals Novel Drug Delivery Systems Products, Services and Solutions
Table 139. Revenue (US$ Million) in Novel Drug Delivery Systems Business of TWi Pharmaceuticals (2020-2025)
Table 140. TWi Pharmaceuticals Recent Developments
Table 141. Key Raw Materials Lists
Table 142. Raw Materials Key Suppliers Lists
Table 143. Novel Drug Delivery Systems Downstream Customers
Table 144. Novel Drug Delivery Systems Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
Table 148. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Novel Drug Delivery Systems Product Picture
Figure 2. Global Novel Drug Delivery Systems Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Novel Drug Delivery Systems Sales Value (2020-2031) & (US$ Million)
Figure 4. Novel Drug Delivery Systems Report Years Considered
Figure 5. Global Novel Drug Delivery Systems Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Novel Drug Delivery Systems Revenue in 2024
Figure 7. Novel Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Liposomes Picture
Figure 9. PEGylated Proteins & Polypeptides Picture
Figure 10. Polymer Nanoparticle Picture
Figure 11. Protein–drug Conjugates Picture
Figure 12. Others Picture
Figure 13. Global Novel Drug Delivery Systems Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Novel Drug Delivery Systems Sales Value Market Share by Type, 2024 & 2031
Figure 15. Product Picture of Hospitals & Clinic
Figure 16. Product Picture of Cancer Treatment Centers
Figure 17. Product Picture of Others
Figure 18. Global Novel Drug Delivery Systems Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 19. Global Novel Drug Delivery Systems Sales Value Market Share by Application, 2024 & 2031
Figure 20. North America Novel Drug Delivery Systems Sales Value (2020-2031) & (US$ Million)
Figure 21. North America Novel Drug Delivery Systems Sales Value by Country (%), 2024 VS 2031
Figure 22. Europe Novel Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
Figure 23. Europe Novel Drug Delivery Systems Sales Value by Country (%), 2024 VS 2031
Figure 24. Asia Pacific Novel Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
Figure 25. Asia Pacific Novel Drug Delivery Systems Sales Value by Region (%), 2024 VS 2031
Figure 26. South America Novel Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
Figure 27. South America Novel Drug Delivery Systems Sales Value by Country (%), 2024 VS 2031
Figure 28. Middle East & Africa Novel Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
Figure 29. Middle East & Africa Novel Drug Delivery Systems Sales Value by Country (%), 2024 VS 2031
Figure 30. Key Countries/Regions Novel Drug Delivery Systems Sales Value (%), (2020-2031)
Figure 31. United States Novel Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
Figure 32. United States Novel Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
Figure 33. United States Novel Drug Delivery Systems Sales Value by Application (%), 2024 VS 2031
Figure 34. Europe Novel Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
Figure 35. Europe Novel Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
Figure 36. Europe Novel Drug Delivery Systems Sales Value by Application (%), 2024 VS 2031
Figure 37. China Novel Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
Figure 38. China Novel Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
Figure 39. China Novel Drug Delivery Systems Sales Value by Application (%), 2024 VS 2031
Figure 40. Japan Novel Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
Figure 41. Japan Novel Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
Figure 42. Japan Novel Drug Delivery Systems Sales Value by Application (%), 2024 VS 2031
Figure 43. South Korea Novel Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
Figure 44. South Korea Novel Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
Figure 45. South Korea Novel Drug Delivery Systems Sales Value by Application (%), 2024 VS 2031
Figure 46. Southeast Asia Novel Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
Figure 47. Southeast Asia Novel Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
Figure 48. Southeast Asia Novel Drug Delivery Systems Sales Value by Application (%), 2024 VS 2031
Figure 49. India Novel Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
Figure 50. India Novel Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
Figure 51. India Novel Drug Delivery Systems Sales Value by Application (%), 2024 VS 2031
Figure 52. Novel Drug Delivery Systems Industrial Chain
Figure 53. Novel Drug Delivery Systems Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
